Baroda, India

Alpesh Goyani

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alpesh Goyani

Introduction

Alpesh Goyani is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral dosage forms. With a total of 3 patents to his name, Goyani's work reflects his commitment to advancing medical science.

Latest Patents

One of Goyani's latest patents is a parenteral unit dosage form of dihydroergotamine. This innovative formulation comprises an aqueous solution of dihydroergotamine or a pharmaceutically acceptable salt as the sole active ingredient. It includes one or more pH adjusting agents and optionally one or more co-solvents. The pH of this aqueous solution is designed to contain substantially lower amounts of impurities compared to solutions with a pH of 4.0 or less, especially when stored under specific conditions. This advancement is crucial for ensuring the stability and efficacy of the medication over time.

Career Highlights

Throughout his career, Alpesh Goyani has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited and Pharmaceutical Industries Limited. His experience in these organizations has allowed him to hone his skills and contribute to various innovative projects.

Collaborations

Goyani has collaborated with several professionals in his field, including Deepak Singodia and Bhaskar Pallerla. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Alpesh Goyani's contributions to pharmaceutical innovations, particularly in parenteral dosage forms, highlight his expertise and dedication to improving healthcare solutions. His patents and collaborations reflect a commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…